FDA Recommends Tighter Restrictions on Most Popular Prescription Drug Category in the US

Access to opioid-based painkiller medications has been the topic of debate for years – some saying it should be more accessible, others arguing that it should be restricted. With the recent focus on the US opioid epidemic, individual states, industry and the FDA have been moving to increase prescriber education, create abuse resistant products and tighten regulations around opioid based drugs.

On 24 October 2013, the FDA announced it will Continue reading